How government-dependent was PHATHOM PHARMACEUTICALS, INC. in fiscal year 2025?

In fiscal year 2025, US federal contract obligations equal at least 0.0% of PHATHOM PHARMACEUTICALS, INC.'s reported revenue - $0 in federal awards against $175.1M in revenue as filed with the SEC.

Cite as: FACTANKER, https://factanker.com/entity/0a6b5fc7-3b2f-443e-aceb-8dae2bfce436/government-dependency/2025

Fiscal yearRevenue (SEC, as filed)Federal obligationsShareData status
FY 2025$175.1M$0≥ 0.0%contracts only
FY 2024$55.3M$0≥ 0.0%contracts only
Evidence
Revenue FY 2025: evidence fact 731a087f… (SEC filing)
Federal obligations FY 2025: sum of 1 award records (USAspending bulk data)
Identity consolidation: CIK 0001783183 · UEI KPGYDW3H7ZW6 - linked via evidence-backed same_as facts, see all facts of this organization
Methodology & sources
Revenue: company fiscal year, as filed with the SEC (XBRL concept per evidence fact). Obligations: US federal fiscal year of the award date, consolidated across all registrations of the corporate group. Computed in the database, precomputed weekly - never by a model. Sources: SEC EDGAR, USAspending (public domain).
Not claimed

Latest fiscal year & all years · PHATHOM PHARMACEUTICALS, INC. - all facts · Use this metric in your own models: JSON/API · API/MCP quickstart